Galera Therapeutics, Inc. 4 SEC Filings

Filed On	Filing
05 Aug 2026	Form 4: Sorensen Mel, Director Returned 975 shares to the issuer · Disposed of 30,000 Stock Option (Right to Buy) (Disposition to Issuer)
05 Aug 2026	Form 4: Lokay Kevin G, Director Disposed of 240 Stock Option (Right to Buy) (Disposition to Issuer)
05 Aug 2026	Form 4: Chang Nancy T, Director Received 661,309 shares by conversion · Returned 47,434 shares to the issuer · Disposed of 480 Stock Option (Right to Buy) (Disposition to Issuer)
05 Aug 2026	Form 4: Alleva Lawrence M, Director Returned 51 shares to the issuer · Disposed of 240 Stock Option (Right to Buy) (Disposition to Issuer)
05 Aug 2026	Form 4: Sussman Joel F., Chief Accounting Officer Disposed of 10,000 Stock Option (Right to Buy) (Disposition to Issuer)
05 Aug 2026	Form 4: Friedman Michael R., Director Received 2,989,399 shares by conversion · Returned 41,631 shares to the issuer · Disposed of 480 Stock Option (Right to Buy) (Disposition to Issuer)
29 May 2026	Form 4: Emerald Bioventures, Llc, 10% owner and 1 other Received 20,813,818 shares by conversion
09 Apr 2026	Form 4: Friedman Michael R., Director Received 5,336,870 shares by conversion
09 Apr 2026	Form 4: Chang Nancy T, Director Received 1,180,611 shares by conversion
24 Nov 2025	Form 4: Sorensen Mel, Director Sold 70,000 shares ($1.41K)
05 May 2025	Form 4: Sussman Joel F., Chief Accounting Officer Granted 2,000,000 Stock Option (Right to Buy)
05 May 2025	Form 4: Sorensen Mel, Director Granted 6,000,000 Stock Option (Right to Buy)
26 Feb 2025	Form 4: Lokay Kevin G, Director Granted 48,000 Stock Option (Right to Buy)
26 Feb 2025	Form 4: Friedman Michael R., Director Granted 96,000 Stock Option (Right to Buy)
26 Feb 2025	Form 4: Chang Nancy T, Director Granted 96,000 Stock Option (Right to Buy)
26 Feb 2025	Form 4: Alleva Lawrence M, Director Granted 48,000 Stock Option (Right to Buy)
02 Jan 2025	Form 4: Chang Nancy T, Director Bought 7,644,932 shares ($500K) · Granted 1,841.92 Series B Preferred Stock
02 Jan 2025	Form 4: Friedman Michael R., Director Granted 8,326.269 Series B Preferred Stock
20 Aug 2024	Form 4: Sorensen Mel, Director Sold 67,015 shares ($4.83K)
26 Feb 2024	Form 4: Schneid Yair, 10% owner Bought 150,000 shares ($27K) · Bought 335,000 shares ($60.6K) · Bought 97,402 shares ($17.9K) · 3 more

Comments